The Korea Disease Control and Prevention Agency (KDCA) will establish the “National Standard Implementation Plan for Medical Devices in 2023” to lead international standards and help domestic medical equipment makers advance overseas.



(Credit: Getty Images)


The main content of the implementation plan includes a push to win the final approval from the International Organization for Standardization (ISO) for two existing international standard plans suggested by Korea, three new international standard plans, and Korea’s hosting of international assemblies for electrical medical products, the agency said Wednesday.


“We are doing our best to ensure that medical device technology in which Korea has strengths can be enacted as the ISO standards,” the KDCA said.


The agency noted that it is continuously participating in ISO’s general assembly and working-group meetings and positively presenting its opinions so that ISO approves the two international standards in dentistry it had submitted this year, adding that it would suggest three new international standard plans this year to lead making international standards in medical devices.


More specifically, KDCA is promoting to get the ISO’s final nods for “general requirements for non-hinged dental handhelds” and “frontal apparatus – part 4: auxiliary apparatus” as international standards in dentistry. In addition, it will push to make three new standards — general requirements for hinged hand tools for dentistry,” “focused tube equipment – part 8: precision of electronic root tube length meter,” and the “classification of dental equipment and devices according to reprocessing – as international standards.


Besides, the agency is pushing to streamline 144 Korea Standards in various areas — 22 standards related to electric and electronic medical devices, 110 related to dental, surgical, and in vitro diagnostic areas, and 12 related to individual medical devices and those used by the vulnerable class.


Meanwhile, the agency plans to hold an international assembly of electric medical devices to be attended by about 150 experts from 20 countries in September to heighten Korea’s status in the international community regarding this field.


The international meetings planned by the agency are the general assembly of the International Electro-technical Commission (IEC) and its technological group, TC (Technical Committee) 62, which deals with electric and mechanical safety, risk management, validation, and data security.


In these meetings, participants will discuss and decide on making and revising international standards regarding electrical medical products’ safety and essential function, including diagnostic imaging devices and radiation devices, the agency said.


“We will communicate with relevant experts based on regulatory expertise and maintain national standards (KS) continuously to ensure that the public can use high-quality medical devices with confirmed safety and high performance,” the KDCA said. “In addition, by reflecting Korea’s strong technical standards in the field of medical devices in international standards, we will actively support to enhance the status of the domestic medical device industry and help K-medical devices advance into overseas markets.
YANGZHOU, China, Feb. 21, 2023 /PRNewswire/ — Meihua International Medical Technologies Co., Ltd. (“MHUA” or the “Company”) (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced the Company, via its subsidiary company Hainan Guoxie Medical Technology Co. (“Hainan Guoxie”), has entered into cooperation agreement (the “Qionghai Agreement”) with Qionghai City of Hainan Province to build technology park project. Hainan Guoxie also entered into cooperation agreement (the “Hope City Agreement”) with Hainan Free Trade Port Boao Hope City (“Hope City”) to build MHUA a medical research and development center in the Hope City.
Pursuant to the Qionghai Agreement, Hainan Guoxie plans to invest in the construction of a medical industrial park in Hainan Province for the will be focused on the development of minimally invasive interventional medical devices, new materials and surgical robotics technologies. Hainan Guoxie and Qionghai City government reached preliminary agreement to bid for the usage of nearly 574,080 sq ft of land around Hope City for the construction of a Contract Development and Manufacturing Organization (CDMO) medical industrial park. The Company anticipates making a more detailed public announcement of the land use right purchase information in about one month’s time.
Pursuant to the Hope City Agreement, the planned MHUA medical R&D center will carry out the research and development of stem cell to human targeted therapies and rehabilitation training projects.
Presently, Hope City is the only special medical parkin China, which was approved by China State Council in 2013 and offers a series of special policies such as “licensed medical treatment, licensed research, licensed operation and licensed international medical technology exchange,” and is a key project for the construction of the Hainan Free Trade Port. At present, there are 20 medical institutions involved in more than 10 projects under construction or planned in the pipeline, with 51 medical academicians forming the expert advisory team. In addition, Hope City has established cooperation with 30 of the top international pharmaceutical and medical devices enterprises, serving as one of the main channels for the importation of innovative products into China. The volume of licensed medicines and medical devices imported has exceeded 200 categories, effectively facilitating the advancement of medical technology, devices and medicine development in China to catch up with the international market.
MHUA’s project is highly valued by the local government of Hope City, who recently paid a special visit to the Company’s headquarters. Mr. Liu Yongjun, chairman of MHUA, commented: “Hainan has many advantageous conditions as China’s national free trade port, which will provide many convenience for MHUA’s products exporting to foreign markets, new product research and development, and taxation, among other things. It is a great honor for us that Qionghai City and Hope City selected the Company as one of the contracted companies to promote medical industry projects locally. MHUA will strive to improve the level of intelligence, information technology, digitalization and innovation, and accelerate the transformation and upgrade of our business, in order to promote the Company’s high-quality development and create sustainable value for our shareholders.”
About Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies is a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China. The Company manufactures and sells Class I disposable medical devices, such as eye drop bottles, medicine bottles and anal bags, and Class II and III disposable medical devices, such as identification tape, gynecological examination kits, inspection kits, surgical kits, medical brushes, medical dressing, masks, disposable infusion pumps, electronic pumps and puncture kits, which products are sold under its own brands and also sourced and distributed from other manufacturers. The Company has received international “CE” certification and ISO 13485 system certification and has also registered with the FDA (registration number: 3006554788) for more than 20 products. The Company has served hospitals, pharmacies, medical institutions and medical equipment companies for over 30 years, providing more than 800 types of products for domestic sales, as well as 120 products which are exported to more than 30 countries internationally across Europe, North America, South America, Asia, Africa and Oceania. For more information, please visit www.meihuamed.com.
Forward-Looking Statements
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company’s ability to achieve its goals and strategies, and its ability to fully execute on the planned agreement, the Company’s future business development and plans of future business development, including its ability to successfully develop robotic assisted surgery systems and obtain licensure and certification for such systems, financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, fluctuations in general economic and business conditions in China, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC”). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, including under the section entitled “Risk Factors” in its annual report on Form 20-F, as filed with the SEC on July 29, 2022, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
Investigation from the revolutionary Honoris Medical Simulation Middle in Tunis was introduced at the Global Assembly on Simulation in Healthcare in Orlando, Usa
We continue to give distinctive obtain to a depth and breadth of cutting-edge simulation expert services that have not been obtainable right before on a pan-regional level”
— Professor Chadli Dziri MD, Director of the Honoris MSC
TUNIS, TUNISIA, January 24, 2023 /EINPresswire.com/ — Honoris United Universities (HUU) attended the world’s premier meeting committed to innovation in the field of health care simulation (IMSH 2023). The Honoris Professional medical Simulation Heart in Tunis, Tunisia presented the results of a randomized managed trial in professional medical simulation carried out at its planet-class facility.
Led by the Culture for Simulation in Healthcare (SSH), the Global Meeting on Simulation in Healthcare (IMSH) is the largest scientific conference devoted to the most up-to-date innovations and most effective techniques in health-related simulation. Chadli DZIRI, MD, FACS, Professor Emeritus of Standard Operation at the Faculty of Medication of Tunis – Tunis El Manar University, Director of the Honoris Medical Simulation Middle, Fellow of the American School of Surgeons, and Member of the Board of Administrators of the American Journal of Surgical treatment, presented at the summit the effects of a randomized controlled demo involving additional than 170 2nd-calendar year Honoris well being university nursing learners, concentrating on health-related pedagogy and evaluating two education approaches: LFS (model) low-fidelity simulation as opposed to standardized individual schooling (SP) for peripheral venous line placement. The abstract of the cross over randomized trial was selected by the SSH organizers. The research protocol has been registered on the Pan African Clinical Demo Registry web site: PACTR202111766112898.
Established in 2018, the cutting-edge Honoris Healthcare Simulation Centre (MSC) is found in the coronary heart of Tunis. It was formulated in coordination with worldwide authorities and utilizing innovative technologies. In 2020, the MSC was a person of the initially centers in Africa to be accredited by SSH: one particular of three accredited facilities among eleven on the continent. The centre provides 4 simulation models like model systems in a hospital setting, state of affairs-primarily based simulations, actor-centered simulations, and cutting-edge virtual truth systems. Far more than 5,000 pupils, 400 health care industry experts, and far more than 60 obstetricians from Northern and Sub-Saharan Africa have been skilled at this facility.
Professor Chadli Dziri MD, Director of the Honoris MSC in Tunis, commented, “Our existence at this year’s IMSH was a wonderful chance to share our finest practice and findings from the use of our know-how and innovative strategies, constantly screening and learning to strengthen each learner and individual results. I am happy that the Honoris Health care Simulation Centre is noticed as a reference issue for international professional medical simulation as we continue on to provide one of a kind obtain to a depth and breadth of slicing-edge simulation services that have not been obtainable in advance of on a pan-regional degree.”
Provided its special network in instruction in Africa, Honoris is fully commited to continuing publishing educational analysis from its facilities of excellence, significantly in the crucial employability sectors for Africa together with well being sciences, organization, and engineering & IT. By encouraging analysis collaborations throughout establishments in numerous markets, Honoris can harness the collective power of its pan-African system and apply health tech remedies and immersive finding out technologies to advance training and finding out in its hubs in Tunisia, Morocco, Nigeria, and South Africa. To continually boost results for its student population of more than 40 nationalities, Honoris plans to broaden its clinical simulation providing to Nigeria and Morocco in the small expression.
Each 12 months, IMSH offers the instruments and resources health care specialists need to advance their abilities, impact change in supply programs and follow, and, in the long run, strengthen individual security. With in excess of 4,000 attendees in 2022, the function welcomes attendees from all about the earth like scientists, academics, medical professionals, and innovators for networking, arms-on workshops, plenary speakers, 300 education periods, and an exhibit hall for the most recent solutions and expert services in the sector.
For Media Info James Deacon, Communications Manager, Honoris United Universities jdeacon@honoris.web
NEW YORK, NY, Dec. 19, 2022 (Globe NEWSWIRE) — Romanian startup Feeling4Healthy, founded by Antonio Enache (CEO), alongside one another with a number of seasoned business owners and programmers, is set to checklist its SFIT token on two cryptocurrency exchanges this December. The organization aims to turn into the most vital player in the blockchain field in the international wellness current market.
The Sense4Healthy exercise application is described by Antonio Enache as “a expert and economical resolution for an active and healthful way of life”. The startup has now lifted in excess of $2 million in funding from investors in the past calendar year and options to record its token on worldwide cryptocurrency exchanges this December.
The selection is aimed at growing the startup’s operations outdoors Romania, predominantly in the US and Asia, by listing on the Bitmart platform, where 65{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of end users are registered in the aforementioned locations. In the last 24 hours, the trade had a buying and selling quantity of practically 700 million bucks and in the previous 7 days it registered extra than 1.3 million visits.
Token listing on two exchanges, set on 19th of December
The second exchange in which the governance token of the Feeling4Fit group will be detailed is a regionally renowned 1: MultiversX, component of the Elrond community, the most profitable venture in the Romanian cryptocurrency industry.
Starting up with December 19th, the Sense4In good shape community token will also be accessible in the Maiar app, the most well known electronic wallet in Romania. Much more than just one million Romanians who have a Maiar transaction account will be ready to spend in the SFIT token commencing subsequent 7 days. For a supercharged adoption of the token, SFIT will also be discovered instantly on Metabonding which is the ultimate local community bootstrapping software from MultiversX.
The startup’s purpose is to build a massive, decentralized ecosystem centered on blockchain technological innovation that can assistance customers live a more healthy life style. Applying the most recent digital systems, the startup is able to provide a holistic experience created to suit any user’s health ambitions. Much more than 450 qualified health and fitness videos from 30 leading physical fitness coaches can be discovered with committed classes and courses. At the very same time, the app presents buyers the alternative to receive cash in authentic time, revolutionizing the wellness and conditioning merchandise market, employing a decentralized financial design, formulated by a workforce of professionals, known as In shape2Earn.
These experiences will be connected together by means of the SFIT utility token, which will have several use circumstances in just the ecosystem: rewards, payments, staking and extra.
Authorities in small business, physical fitness, AI and blockchain perform for Perception4Match
The startup was launched by entrepreneur Antonio Enache (CEO), who has over 15 years of experience in the fitness and wellness company world. He has assembled a workforce of 9 skilled AI scientists, led by Cristian Gherghina, who also will work in Seattle at Microsoft headquarters. Other customers of the undertaking are Valentin Maior (with 13 many years of expertise in application advancement), Florin Mîndru (serial entrepreneur and co-founder of a person of the major schooling and small business organizing platforms focused to romanian business owners), Ionuț Moncea (company owner) and Marius Berbecuț who has extra than 15 several years expertise in the health marketplace.
The complete crew consists of extra than 25 professionals who have invested their know-how from their own fields of exercise to produce a significant-functionality health product or service through blockchain technology. The application integrates synthetic intelligence features, augmented reality and gives a selection of exercises executed and recorded by fitness professionals. The In shape2Get paid Website3 system lets buyers to get paid authentic-time benefits by means of training problems with terrific gameplay and promotes a balanced way of living amid the group.
From authentic existence, to the Metaverse
The Perception4In shape ecosystem features the world’s very first decentralised exercise application, combining in one position all the means wanted by customers in purchase to make improvements to their life-style and, as a result, their health. In 2023, the startup will also launch a network of franchised fitness golf equipment that will enable the opening of their have gymnasium, the sale of memberships, and a digital workout room. The digital exercise community will be referred to as “Metaverse Wellness” and is predicted to start in 2023.
Prostate cancer occurs when the cells in the prostate gland which is found only in males start to grow out of control. Prostate gland is located just below the bladder and in front of the rectum and makes some of the fluid that is part of semen. Prostate cancer is the second most common cancer in men worldwide and unfortunately its incidence is increasing in India as it has moved from being the eighth most common cancer in males in 1990s to the third rank by 2015. It is the fifth leading cause of cancer-related deaths among men worldwide. (Also read: Prostate Cancer: Causes, symptoms, risk factors and treatment)
Can one prevent the prostate cancer? There are certain risk factors like age, race and genetics that cannot be modified while lifestyle factors can be modified to an extent.
“There is no proven strategy to prevent prostate cancer. Prostate cancer is primarily a disease of aging. As you get older, your chances of developing prostate cancer increase. Race and genetics also play a significant role. If your father, brother or multiple blood relatives had prostate cancer, you are more likely to get it, too. Worldwide African Americans have increased risk of having prostate cancer. These risk factors of age, race and genetics are non-modifiable risk factors. Preventing prostate cancer might be difficult if you have these risk factors, but screening early and often can help ensure that if you do get cancer, it’s diagnosed and treated as soon as possible,” says Dr Shrikanth Atluri, Consultant Uro-Oncologist and Robotic Surgeon within the division of Surgical Oncology (Cancer Surgery) at Sir HN Reliance Foundation Hospital, Mumbai.
LIFESTYLE FACTORS THAT INCREASE RISK OF PROSTATE CANCER
A wide variety of environmental or dietary factors may be associated with the risk of developing prostate cancer.
“Poor eating habits and diets that heavily rely on fats and animal proteins can cause DNA damage and lead to cancer. Even men who are already at greater risk due to age, race or genetics can reduce their chances of developing prostate cancer by adopting healthy diets and lifestyles. Improve your diet by reducing fat, charred meat, eating more fruits and vegetables, maintain healthy weight, regular exercise, stop smoking and drinking are the lifestyle changes to be adopted to which may help in reducing the risk of having a prostate cancer,” says Dr Atluri.
Dr. Preetam Kumar Jain – Senior Consultant Oncologist and Hematologist, Masina Hospital, says that although there is no definite method to reduce the risk of prostate cancer and certain risk factors are irreversible, there are studies that reversible risk factors when controlled can help in reducing the risk of prostate cancers. Dr Jain suggests some tips.
TIPS TO REDUCE RISK OF PROSTATE CANCER
– Healthy lifestyle: One should stay away from unhealthy food, eat nutritious food and sleep on time.
– Regular exercise: One should exercise 20 minutes a day and 5 days a week.
– Avoid Obesity: Staying physically active and eating healthy food can help. Weight problems should be addressed early.
– Maintain Body mass index
– Eating diets rich in antioxidants such as fruits and vegetables can help reduce risk of prostate cancer.
– Do not go overboard with dairy products and calcium content.
– Avoid diet containing red and processed meats.
– Some studies say that drugs that inhibit 5 alpha reductase inhibitors and aspirin may reduce the reduce the risk of prostate cancer and mortality. However, they are not FDA recommended as of now.
“It is also important to identify early symptoms of prostate related problem. Symptoms like frequent micturition, incomplete voiding of urine, nocturia, could be possible signs of prostate related problems. If you have a family history of prostate cancer, then the subsequent generation members are at a risk of prostate cancer, at least a decade earlier. Knowing this genetic susceptibility, you may have to remain alert as your age advances. New genetic studies are in the pipeline for better understanding of the prostate cancer. Mutation analysis like BRCA and HRR testing are now being recommended in patients with prostate cancer,” says Dr Jain.

